Dynamic Changes in Circulatory Cytokines and Chemokines Levels in Mild to Severe COVID-19 Patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J Med Virol. 2022;94(4):1641–9. https://doi.org/10.1002/jmv.27526.
Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):1–1.
Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19(7):102567. https://doi.org/10.1016/j.autrev.2020.102567.
Ye CH, Hsu WL, Peng GR, Yu WC, Lin WC, Hu S, et al. Role of the immune microenvironment in SARS-CoV-2 infection. Cell Transplant. 2021;3(30):09636897211010632.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinon-Torres F. Role of monocytes/macrophages in Covid-19 pathogenesis: implications for therapy. Infect Drug Resist. 2020;13:2485. https://doi.org/10.2147/IDR.S258639.
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions. Life Sci. 2020;257:118102. https://doi.org/10.1016/j.lfs.2020.118102.
Zhou R, To KK, Wong YC, Liu L, Zhou B, Li X, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53(4):864–77. https://doi.org/10.1016/j.immuni.2020.07.026.
Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–62.
Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.01446.
Lucas C, Wong P, Klein J, Castro TB, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463–9.
Mohandas P, Periasamy S, Marappan M, Sampath A, Sundaram VK, Cherian VK. Clinical review of COVID-19 patients presenting to a quaternary care private hospital in South India: a retrospective study. Clin Epidemiology Glob Health. 2021;11:100751. https://doi.org/10.1016/j.cegh.2021.100751.
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1–9. https://doi.org/10.12932/AP-200220-0772.
Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, et al. Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur J Immunol. 1996;26(7):1647–51. https://doi.org/10.1002/eji.1830260736.
O'Shea JJ, Gadina M, Siegel RM. Cytokines and cytokine receptors. In: Clinical Immunology: Elsevier; 2019. pp. 127–155. https://doi.org/10.1016/B978-0-7020-6896-6.00009-0.
Sun X, Wang T, Cai D, Hu Z, Liao H, Zhi L, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev. 2020;53:38–42. https://doi.org/10.1016/j.cytogfr.2020.04.002.
Ploegh HL. Viral strategies of immune evasion. Science. 1998;280(5361):248–53. https://doi.org/10.1126/science.280.5361.248.
Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virol. 2006;344(1):119–30. https://doi.org/10.1016/j.virol.2005.09.024.
Hayney MS, Henriquez KM, Barnet JH, Ewers T, Champion HM, Flannery S, et al. Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults. J Clin Virol. 2017;90:32–7. https://doi.org/10.1016/j.jcv.2017.03.003.
Almansa R, Sanchez-Garcia M, Herrero A, Calzada S, Roig V, Barbado J, et al. Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease. J Interferon Cytokine Res. 2011;31(5):409–13. https://doi.org/10.1089/jir.2010.0131.
Henriquez KM, Hayney MS, Xie Y, Zhang Z, Barrett B. Association of interleukin-8 and neutrophils with nasal symptom severity during acute respiratory infection. J Med Virol. 2015;87(2):330–7. https://doi.org/10.1002/jmv.24042.
Apolinario A, Majano PL, Alvarez-Pérez E, Saez A, Lozano C, Vargas J, et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol. 2002;97(11):2861–70. https://doi.org/10.1016/S0002-9270(02)05471-0.
Salazar-Mather TP, Hamilton TA, Biron CA. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest. 2000;105(7):985–93.
Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell LB, et al. Requirement of MIP-1α for an inflammatory response to viral infection. Science. 1995;269(5230):1583–5. https://doi.org/10.1126/science.7667639.
Trumpfheller C, Tenner-Racz K, Racz P, Fleischer B, Frosch S. Expression of macrophage inflammatory protein (MIP)-1α, MIP-1β, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response. Clin Exp Immunol. 1998;112(1):92–9. https://doi.org/10.1046/j.1365-2249.1998.00555.x.
Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol. 1996;157(8):3598–604.
Liu Y, Liao W, Wan L, Xiang T, Zhang W. Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19. Viral Immunol. 2021;34(5):330–5. https://doi.org/10.1089/vim.2020.0062.
McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202(6):812–21. https://doi.org/10.1164/rccm.202005-1583OC.
Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004;72(8):4410–5. https://doi.org/10.1128/IAI.72.8.4410-4415.2004.